CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

A study has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for detecting abnormal brain beta-amyloid pathology, a hallmark of Alzheimer's disease.

Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision ... The first similar ...

Art Still is one of the best defensive ends in University of Kentucky football history, becoming the No. 2 overall pick in ...

Rece Hinds can build a nice career in the Cincinnati Reds’ outfield by showing the ability to adjust. Little did he know that ...

Subtle changes in the eyes can reveal serious health issues like dementia, diabetes, and high cholesterol. The eyes can ...

They also divided NSAIDs into two categories: beta-amyloid-42-lowering or non-beta-amyloid-42-lowering. This distinction had to do with previous data on how certain NSAIDs may affect amyloid ...

Researchers did not find a significant difference in their accumulation of amyloid beta, another toxic protein linked to Alzheimer’s. “Approximately a quarter of currently postmenopausal women who are ...

However, up to 10% of people with Crohn’s also experience irritation and inflammation in one or both eyes. Crohn’s-related eye disorders can be painful. In rare cases, they can lead to vision ...

An RNAi therapy, Amvuttra is already approved to treat polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis and would add a differentiated mechanism to the ATTR-CM treatment toolbox ...

Aug. 23, 2021 — Amyloid plaques found in the retinas of eyes may be an indicator of similar plaques in the brain, a hallmark of Alzheimer's disease, and may provide a more visible biomarker for ...